ProfileGDS4132 / 1558773_s_at
TitlePPAR-γ agonist pioglitazone effect on obese women with polycystic ovary syndrome: skeletal muscle
OrganismHomo sapiens


pretreatment pioglitazone GSM201542 GSM201543 GSM201544 GSM201545 GSM201829 GSM201830 GSM201831 GSM201832 GSM201833 GSM201834 GSM201835 GSM201836 GSM201837 GSM201838 GSM201839 GSM201840 GSM201841 GSM201842 GSM201843 GSM201844 31% 26% 40% 33% 39% 37% 28% 35% 25% 29% 22% 24% 20% 32% 30% 26% 22% 28% 23% 23% sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM201542Muscle PCOS pioglitazone 10176.339531
GSM201543Muscle PCOS pioglitazone 12155.453826
GSM201544Muscle PCOS pioglitazone 161104.5540
GSM201545Muscle PCOS pioglitazone 20191.543733
GSM201829Muscle PCOS pioglitazone 231108.4139
GSM201830Muscle PCOS pioglitazon 25199.464237
GSM201831Muscle PCOS pioglitazone 27165.260228
GSM201832Muscle PCOS pioglitazone 3188.910135
GSM201833Muscle PCOS pioglitazone 4156.06225
GSM201834Muscle PCOS pioglitazone 8168.447529
GSM201835Muscle PCOS after pioglitazone 10237.307622
GSM201836Muscle PCOS after pioglitazone 12247.79824
GSM201837Muscle PCOS after pioglitazone 16235.012420
GSM201838Muscle PCOS after pioglitazone 20270.368432
GSM201839Muscle PCOS after pioglitazone 23267.788230
GSM201840Muscle PCOS after pioglitazone 25259.275526
GSM201841Muscle PCOS after pioglitazone 27239.368122
GSM201842Muscle PCOS after pioglitazone 3253.122328
GSM201843Muscle PCOS after pioglitazone 4253.855723
GSM201844Muscle PCOS after pioglitazone 8249.641923